HIGH-THROUGHPUT CELL ANALYSIS CORE 1. MAIN OBJECTIVES AND NEW DIRECTIONS Many of the major advances in tumor biology and immunology were made possible by the ability to rapidly discriminate and isolate discrete cell populations. The Burnham Institute for Medical Research (BIMR) High Throughput Cell Analysis (HTCA) facility was established in 2002 to provide high-speed cell sorting, analytical cytometry and high-throughput microscopy provides this capability to members of the NIH-funded BIMR Cancer Center. Currently, this facility is not available to La Jolla Torrey Pines Mesa neuroscientists;therefore, the current lack of general access to modern cytometry, especially image-based high-throughput microscopy with advanced image algorithms design support, as provided in this Core, imposes restrictions on the range of experimental design by neuroscientists in San Diego. Moreover the HTCA Core interacts extensively with the Chemical Screening Library (CSL) Core (see separate write up of that core) in screening for lead compounds and for drug actions in cell-based assays. The HTCA Core facility will offer analytical cytometry using two user operated benchtop cytometers (Becton-Dickenson FACSCanto 6-color and BD FACSort 3-color cytometers), a FACSVAntage SE with Digital Option (FACSDiVa) high-speed sorter operated by a skilled specialist, and a Beckman-Coulter Eidaq 100 automated high-throughput microscope. The director of the facility (Dr. Mark Mercola) offers expert consultation and periodic workshops on cytometry. In addition, affiliated faculty at BIMR and UCSD offer advice in imaging algorithms (see below). The current facility has supported a large number of BIMR Cancer investigators at a reduced charge-back rate and offered limited support to outside Cancer users at an external rate. Scientific progress has been impressive, with numerous publications in top-tier journals. The present application will make this facility available to Neuroscientists as a Core Unit. As mentioned above, Facility staff work closely with the Chemical Library Screening facility, located contiguously at the BIMR, to support the design and optimization of high-throughput cell-based screening assays.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS057096-04
Application #
7925699
Study Section
Special Emphasis Panel (ZNS1)
Project Start
2009-09-01
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
4
Fiscal Year
2009
Total Cost
$63,695
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kratter, Ian H; Zahed, Hengameh; Lau, Alice et al. (2016) Serine 421 regulates mutant huntingtin toxicity and clearance in mice. J Clin Invest 126:3585-97
Kim, Changyoun; Lee, He-Jin; Masliah, Eliezer et al. (2016) Non-cell-autonomous Neurotoxicity of ?-synuclein Through Microglial Toll-like Receptor 2. Exp Neurobiol 25:113-9
Singec, Ilyas; Crain, Andrew M; Hou, Junjie et al. (2016) Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling. Stem Cell Reports 7:527-542
Kim, Changyoun; Lv, Guohua; Lee, Jun Sung et al. (2016) Exposure to bacterial endotoxin generates a distinct strain of ?-synuclein fibril. Sci Rep 6:30891
Valera, Elvira; Masliah, Eliezer (2016) Combination therapies: The next logical Step for the treatment of synucleinopathies? Mov Disord 31:225-34
Mandler, Markus; Valera, Elvira; Rockenstein, Edward et al. (2015) Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Mol Neurodegener 10:10
Tang, Bin; Wang, Tingting; Wan, Huida et al. (2015) Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome. Proc Natl Acad Sci U S A 112:E4697-706
Rockenstein, Edward; Overk, Cassia R; Ubhi, Kiren et al. (2015) A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies. PLoS One 10:e0121570
Hoefer, Melanie M; Sanchez, Ana B; Maung, Ricky et al. (2015) Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Exp Neurol 263:221-34
Valera, Elvira; Mante, Michael; Anderson, Scott et al. (2015) Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease. J Neuroinflammation 12:93

Showing the most recent 10 out of 105 publications